undefined undefined
NaN.000
NaN.00%
Adaptimmune Therapeutics(ADAP.US):2024年Q1财报实现营收567.8万美元,前值为4760.1万美元,预期值为1073万美元...
05-15 20:04
Adaptimmune Therapeutics (NASDAQ:ADAP) entered into a $125M five-year, term loan facility with Hercules Capital. The transaction strengthens the company's balance sheet as it executes on its sarcoma f...
05-15 19:36
Major earnings expected before the bell on Wednesday include: Cresco Labs (OTCQX:CRLBF) Dynatrace (DT) Hut 8 (HUT) monday.com (MNDY) 22nd Century Group (XXII) Other earnings slated for release before ...
05-14 22:01
The FDA has approved Roche’s Alecensa for the treatment of early stage resected non-small cell lung cancer, or NSCLC, with ALK+ mutations. Roche said that the approval makes Alecensa the first and onl...
04-19 05:14
Celebrate the mother figure in your life by nominating them to win Lovesac Footsac Blanket STAMFORD, Conn., April 17, 2024 /PRNewswire/ -- The Lovesac Company, the home furnishing and techno...
04-17 21:03
MENLO PARK, Calif., April 16, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced the notice of allowance for a new patent, 17/812,072, for the Company's...
04-16 19:05
Analyst Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Ada...
04-16 14:56
Analysts fell to the sidelines weighing in on Adaptimmune Therapeutics (ADAP – ...
04-16 14:50
Adaptimmune Therapeutics (NASDAQ:ADAP) traded lower premarket Friday after the U.K.-based biotech announced the termination of a multi-year strategic collaboration it struck with Roche's (OTCQX:RHHBY)...
04-12 20:53
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transitioned to a higher dose level, accessing the potential for
04-10 21:09